Skip to content

Comparsion of Gliburide and Insulin in Women With Gestational Diabetes Mellitus and Associated perinatal Outcome

Comparsion of Gliburide and Insulin in Women With Gestational Diabetes Mellitus and Associated perinatal Outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013071010876N2
Enrollment
128
Registered
2014-06-22
Start date
2012-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabet. Diabetes mellitus in pregnancy

Interventions

Intervention 1: in group of intervention glyburide the therapy is usually recommended when standard dietary management dose not consistently maintain the fasting plasma glucose at <90mg/dl or the 2-ho
Treatment - Drugs
in group of intervention glyburide the therapy is usually recommended when standard dietary management dose not consistently maintain the fasting plasma glucose at <90mg/dl or the 2-hour post prandial
in group of control insulin therapy is usually recommended when standard dietary management dose not consistently maintain the fasting plasma glucose at <90mg/dl or the 2-hour post prandial plasm

Sponsors

infertility research center of Shahid Beheshti University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : woman with singelton pregnancy who had gdm between 24 and 36 weeks who failed diet therapy Exclusion criteria: diabetes mellitus; medical complication, e.g.; hypertension or vascular disease; use of tobacco, alcohol; fetal anomaly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: Daily. Method of measurement: mg / dl.

Secondary

MeasureTime frame
NICU admission. Timepoint: After birth. Method of measurement: Day.;Birth weight. Timepoint: After of birth. Method of measurement: gr.;Neonatal blood glucose. Timepoint: After of birth. Method of measurement: mg/ dl.;Neonatal Bilirubin. Timepoint: After birth. Method of measurement: mg/ dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoome Mirzamoradi

Shahid Beheshti University of Medical Siences

drmoradi000@yahoo.com; zfaaalpoor@yahoo.com+98 21 5506 6263

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026